Market Performance
The IPO of Fabtech Technologies continues to witness strong investor interest, achieving 157% subscription on the third day of bidding. The momentum reflects significant appetite across all investor categories.
- Total bids received: 1,89,50,925 shares
- Shares on offer: 1,20,60,000 shares
The breakdown of subscriptions shows widespread participation:
- Qualified Institutional Buyers (QIBs): 136% subscribed
- Non-Institutional Investors: 163% subscribed
- Retail Individual Investors (RIIs): 184% subscribed
Main News
Fabtech Technologies’ initial public offer is set at a price band of ₹181-191 per share. The IPO, entirely a fresh issue, is designed to raise up to ₹230 crore at the upper limit of the price band. The strong subscription on Day 3 underlines investor confidence in the company’s business model and growth potential.
The proceeds from the IPO are earmarked for multiple strategic purposes:
- Funding working capital requirements
- Pursuing inorganic growth initiatives through acquisitions
- General corporate purposes
Company Details
Fabtech Technologies specializes in end-to-end solutions for pharmaceutical equipment, covering design, engineering, procurement, installation, and testing.
- Projects completed till June 2024: 35
- Countries served: Saudi Arabia, Egypt, Algeria, Bangladesh, Ethiopia, Sri Lanka, UAE
The company’s footprint across diverse international markets underscores its capability in delivering comprehensive solutions and maintaining operational excellence.
Summary
Fabtech Technologies’ IPO has garnered robust response, achieving 157% subscription on the third day of bidding. With a total issue size of ₹230 crorethe fresh issue at the top end of the price band aims to fund growth initiatives and strengthen working capital. The company’s global project experience and end-to-end pharmaceutical solutions highlight its strategic positioning in the market.
Easy & quick
Leave A Comment?